CACI International has blown past its pre-earnings consensus in a single week, leaving analysts scrambling and shorts sitting on painful marks.
The week's standout is the earnings reaction itself. CACI posted a next-day move of roughly 20% on August 5, with a further 24% follow-through reading on August 6 — the biggest post-earnings swing the stock has seen in recent memory. From there the stock has continued adding, closing Friday at $644.43, up 29.5% on the week. The prior notes flagged bullish options positioning ahead of the print, with call volume running at three times put volume. That bet paid off. The PCR has since eased to 0.36, still below its 20-day average of 0.41, and the z-score has moderated to -0.22 — meaning the options market is no longer pricing in the same urgency but hasn't flipped defensive either.
Lending conditions tell a relaxed story, consistent with a stock where shorts are not being squeezed into a corner. Availability is ample at 637% of short interest — well above the normal range — and has been broadly stable throughout the month. Cost to borrow has ticked up 27% on the week to 0.61%, but in absolute terms that remains trivially low, and the 52-week peak utilization of 17.2% confirms this was never a heavily contested borrow. Short interest at 6.0% of the free float has barely moved — down just 1.1% on the week after ticking up slightly on Monday and Tuesday — suggesting shorts have not aggressively covered into the rally. That is a notable detail: a 29% weekly move with no meaningful short covering points to real buying demand rather than a mechanical squeeze.
The analyst community is now moving hard in CACI's direction after months of trimming targets into weakness. UBS raised its target to $804 from $598 on Friday while maintaining Buy — a $206 lift that reflects genuine fundamental revision, not a minor housekeeping update. JP Morgan also lifted to $715 from $645 the same day. Both moves came after the print, and both still leave the consensus mean at $676, a shade above where the stock trades today. That sets up an interesting tension: the two most recent movers are well above consensus, which means the average will drift higher as the rest of the Street catches up. TD Cowen, Jefferies, and Citi all cut targets aggressively in June and July — to $550, $510, and $519 respectively — and all now look stale relative to the stock's current level. The EPS momentum factor score backs the post-print optimism, ranking in the 92nd percentile on 30-day and 90th on 90-day basis, which places CACI near the top of its universe for forward earnings revision momentum.
The bull and bear debate has materially shifted ground after the print. The bear case — centred on the FQ2 revenue miss, the 0.6x book-to-bill, and a shrinking $4.4 billion funded backlog — no longer carries the weight it did heading into the week. The bull case, built on free cash flow ($281 million year-to-date through FQ1), a raised revenue guidance range of $9.3–$9.5 billion for fiscal 2026, and mid-single-digit growth targets, is now the dominant framing. Peer performance was also strong across the board: LDOS gained 19% on the week and BAH added 9.1%, confirming a broad re-rating in government IT rather than a CACI-specific outlier. SAIC lagged at 8%, and KBR gained a more modest 3.9%, suggesting investors are still distinguishing between names.
The next scheduled event is the Q1 FY2027 earnings call on October 21. Between now and then, the key question is whether the remaining bears — those who cut targets to the $500s and haven't yet revised — move their numbers closer to where UBS and JPM are now, and whether the funded backlog trend stabilises enough to make the book-to-bill concern feel like a one-quarter anomaly rather than a structural shift.
See the live data behind this article on ORTEX.
Open CACI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
